Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;75(1):224-226.
doi: 10.1016/j.jhep.2021.03.009. Epub 2021 Mar 20.

Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

Affiliations
Comment

Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

Javier Crespo et al. J Hepatol. 2021 Jul.
No abstract available

Keywords: COVID-19; SARS-CoV2 vaccination; Viral hepatitis elimination; hepatitis C screening.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests All authors have nothing to declare. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

  • Impact of COVID-19 on global HCV elimination efforts.
    Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A. Blach S, et al. J Hepatol. 2021 Jan;74(1):31-36. doi: 10.1016/j.jhep.2020.07.042. Epub 2020 Aug 7. J Hepatol. 2021. PMID: 32777322 Free PMC article.

References

    1. Gamkrelidze I., Pawlotsky J., Lazarus J.V., Feld J.J., Zeuzem S., Bao Y., et al. Progress towards hepatitis C virus elimination in high-income countries: an updated analysis. Liver Int. 2021;41(3):456–463. doi: 10.1111/liv.14779. - DOI - PubMed
    1. Wingrove C., Ferrier L., James C., Wang S. The impact of COVID-19 on hepatitis elimination. Lancet Gastroenterol Hepatol. 2020;5(9):792–794. doi: 10.1016/S2468-1253(20)30238-7. - DOI - PMC - PubMed
    1. Gray D.M., Anyane-Yeboa A., Balzora S., Issaka R.B., May F.P. COVID-19 and the other pandemic: populations made vulnerable by systemic inequity. Nat Rev Gastroenterol Hepatol. 2020;17(9):520–522. doi: 10.1016/S2468-1253(20)30238-7. - DOI - PMC - PubMed
    1. Blach S., Kondili L.A., Aghemo A., Cai Z., Dugan E., Estes C., et al. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021;74(1):31–36. doi: 10.1016/j.jhep.2020.07.042. - DOI - PMC - PubMed
    1. Buti M., Domínguez-Hernández R., Casado M.A. Impact of the COVID 19 pandemic on HCV elimination in Spain. J Hepatol. 2021;74(5):1246–1248. doi: 10.1016/j.jhep.2020.12.018. - DOI - PMC - PubMed